Tricaprylin
三辛酸甘油酯
Report date: 2023/04/15 20:00:50
NME
Base Information
Drug NameTricaprylin
Drug Alias Name +[10]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaIND
Originator CompaniesAccera Inc
China Registration ClassN/A
Develop Information
Active CompaniesIqvia Rds (Shanghai) Co LtdCerecin Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A